Please use this identifier to cite or link to this item:
Title: PBF509, an adenosine A(2A) receptor antagonist with efficacy in rodent models of movement disorders
Author: Núñez, Fabiana
Taura, Jaume
Camacho, Juan
López-Cano, Marc
Fernández Dueñas, Víctor
Castro, Naomi
Castro, Julio
Ciruela Alférez, Francisco
Keywords: Malaltia de Parkinson
Receptors neurals
Parkinson's disease
Neural receptor
Issue Date: 10-Oct-2018
Publisher: Frontiers Media
Abstract: Adenosine A2A receptor (A2AR) antagonists have emerged as complementary non-dopaminergic drugs to alleviate Parkinson's disease (PD) symptomatology. Here, we characterize a novel non-xhantine non-furan A2AR antagonist, PBF509, as a potential pro-dopaminergic drug for PD management. First, PBF509 was shown to be a highly potent ligand at the human A2AR, since it antagonized A2AR agonist-mediated cAMP accumulation and impedance responses with KB values of 72.8 ± 17.4 and 8.2 ± 4.2 nM, respectively. Notably, these results validated our new A2AR-based label-free assay as a robust and sensitive approach to characterize A2AR ligands. Next, we evaluated the efficacy of PBF509 reversing motor impairments in several rat models of movement disorders, including catalepsy, tremor, and hemiparkinsonism. Thus, PBF509 (orally) antagonized haloperidol-mediated catalepsy, reduced pilocarpine-induced tremulous jaw movements and potentiated the number of contralateral rotations induced by L-3,4-dihydroxyphenylalanine (L-DOPA) in unilaterally 6-OHDA-lesioned rats. Moreover, PBF509 (3 mg/kg) inhibited L-DOPA-induced dyskinesia (LID), showing not only its efficacy on reversing parkinsonian motor impairments but also acting as antidyskinetic agent. Overall, here we describe a new orally selective A2AR antagonist with potential utility for PD treatment, and for some of the side effects associated to the current pharmacotherapy (i.e., dyskinesia).
Note: Reproducció del document publicat a:
It is part of: Frontiers in Pharmacology, 2018, vol. 9, p. 1200
Related resource:
ISSN: 1663-9812
Appears in Collections:Articles publicats en revistes (Patologia i Terapèutica Experimental)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
682739.pdf1.43 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons